HDAC1 and neoplasm: Current drug progresses related to HDAC1 show that HDACi can increase the acetylation degree of intracellular histones and nonhistones, improve the expression level of P21, P53, and other genes, and then achieve the effect of inhibiting tumor cells [36, 37].